FAKTOR-OPTIONSSCHEIN - AMGEN Share Price

DE000MG1SN09

Market Closed - Börse Stuttgart 12:24:56 15/06/2024 am IST
7.99 ^EUR	+0.25%

Current month	+4.99%
1 month	+8.12%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart AMGEN INC.

Latest news about AMGEN INC.

Amgen Gets FDA Approval to Treat Aggressive Leukemia Type with Blincyto	15/06	DJ
Amgen : Continues to Propel BiTE® Technology Innovation	15/06	PU
Amgen Says FDA Approves Blincyto to Treat Type of Blood Cancer	15/06	MT
FDA APPROVES BLINCYTO® (BLINATUMOMAB) IN CD19-POSITIVE PHILADELPHIA CHROMOSOME-NEGATIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) IN THE CONSOLIDATION PHASE	15/06	PR

More news

Quotes 5-day view

Date	Price	Change
14/24/14	7.99	+0.25%
13/24/13	7.97	+2.84%
12/24/12	7.75	-0.39%
11/24/11	7.78	+2.10%
10/24/10	7.62	+1.33%

Delayed Quote Börse Stuttgart

Last update June 15, 2024 at 12:24 am IST

More quotes

Static data

Product type	Exotic Products
Buy / Sell	CALL
Underlying	AMGEN INC.
Issuer	Morgan Stanley
WKN	MG1SN0
ISIN	DE000MG1SN09
Date issued	05/04/2024
Strike	447.8 $
Maturity	Unlimited
Parity	17.52 : 1
Emission price	10 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	11.17 €
Lowest since issue	6.86 €
Spread	0.02 €
Spread %	0.25%

Company Profile

Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows: - drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.; - other (5.8%): primarily royalties. The United States account for 70.3% of net sales.

Sector

More about the company

Ratings for Amgen Inc.

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Consensus: Amgen Inc.

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

298.6 USD

Average target price

316.4 USD

Spread / Average Target

+5.97%

Consensus